Intracellular delivery of nucleic acids as gene regulation agents typically requires the use of cationic carriers or viral vectors, yet issues related to cellular toxicity or immune responses hamper their attractiveness as therapeutic candidates. The discovery that spherical nucleic acids (SNAs), polyanionic structures comprised of densely packed, highly oriented oligonucleotides covalently attached to the surface of nanoparticles, can effectively enter more than 50 different cell types presents a potential strategy for overcoming the limitations of conventional transfection agents. Unfortunately, little is known about the mechanism of endocytosis of SNAs, including the pathway of entry and specific proteins involved. Here, we demonstrate that the rapid cellular uptake kinetics and intracellular transport of SNAs stem from the arrangement of oligonucleotides into a 3D architecture, which supports their targeting of class A scavenger receptors and endocytosis via a lipid-raft-dependent, caveolae-mediated pathway. These results reinforce the notion that SNAs can serve as therapeutic payloads and targeting structures to engage biological pathways not readily accessible with linear oligonucleotides.
Intracellular delivery of nucleic acids as gene regulation agents typically requires the use of cationic carriers or viral vectors, yet issues related to cellular toxicity or immune responses hamper their attractiveness as therapeutic candidates. The discovery that spherical nucleic acids (SNAs), polyanionic structures comprised of densely packed, highly oriented oligonucleotides covalently attached to the surface of nanoparticles, can effectively enter more than 50 different cell types presents a potential strategy for overcoming the limitations of conventional transfection agents. Unfortunately, little is known about the mechanism of endocytosis of SNAs, including the pathway of entry and specific proteins involved. Here, we demonstrate that the rapid cellular uptake kinetics and intracellular transport of SNAs stem from the arrangement of oligonucleotides into a 3D architecture, which supports their targeting of class A scavenger receptors and endocytosis via a lipid-raft-dependent, caveolae-mediated pathway. These results reinforce the notion that SNAs can serve as therapeutic payloads and targeting structures to engage biological pathways not readily accessible with linear oligonucleotides. S pherical nucleic acids (SNAs) represent an emerging class of nucleic acids distinct from linear nucleic acids in the context of gene regulation (1, 2) . These nanostructures, although polyanionic like their linear counterparts, can naturally traverse the negatively charged cell membrane and enter cells. By contrast, linear nucleic acids of the same sequence typically require the use of cationic transfection agents to overcome the coulombic repulsive forces between the cell membrane and their phosphate backbone. For example, when C166 (mouse endothelial) cells are treated with Cyanine 5 (Cy5)-labeled, single-stranded oligonucleotides (1 μM, Cy5-ssDNAs; sequence information listed in Table S1 ), confocal microscopy after 2 h of incubation revealed no appreciable uptake (Fig. 1A) . However, when the cells are treated with Cy5-SNAs made from Cy5-ssDNAs of identical sequence covalently attached to the surface of spherical gold nanoparticles (AuNPs) (10 nM particles with ∼100 oligonucleotides per particle; Fig. S1 ), significant intracellular accumulation could be observed (Fig. 1B) . Note that the SNAs are at 1/100 the concentration of the free oligonucleotides, and on a total DNA basis, both experiments contain identical nucleic acid amounts. Even by complexing oligonucleotides of the same sequence with DharmaFECT, a conventional cationic transfection agent, the resultant polycation/ oligonucleotide complexes are primarily localized on the cell membrane without significant intracellular accumulation over the same 2 h time period (Fig. 1C) . Thus, SNAs appear to mediate the endocytosis of oligonucleotides using a mechanism that is different from the electrostatic interactions exploited by many cationic transfection agents. We further monitored the endocytosis of Cy5-labeled "hollow SNAs," 3D oligonucleotide-based constructs obtained by crosslinking multiple alkyne-containing Cy5-ssDNAs on the surface of an AuNP core that was subsequently dissolved with KCN (3). Hollow SNAs enter cells at a rate and to an extent similar to those observed for Cy5-SNAs with the core, reinforcing the notion that the 3D oligonucleotide shell, and not the nature of the NP core, is the dominant factor governing the endocytosis of SNAs (Fig. 1D) .
Since SNAs have been heavily used in intracellular detection (4) and gene regulation (5) applications, it is imperative that the biological mechanism that governs their endocytosis be determined. In this work, we have monitored the cellular uptake kinetics and intracellular transport of SNAs, determined their primary entry pathway, and identified the primary receptor subclass that mediates their internalization into mammalian cells.
Results and Discussion
Cellular Uptake Kinetics and Intracellular Transport. To probe the biological effects due to the 3D arrangement of oligonucleotides that comprise SNAs, we first characterized their cellular uptake kinetics and intracellular transport. We performed all cell culture experiments by incubating C166 cells with SNAs formulated in Opti-MEM I reduced serum media (OptiMEM) to exclude the effects of serum proteins on the endocytosis mechanism. After incubation of cells with SNAs over different durations of time, we used inductively coupled plasma mass spectrometry (ICP-MS) to quantify the rate of SNA cellular association. The most rapid SNA association occurs within the first 30 min, as evidenced by the rapid rise in gold content ( Fig. 2A) . After 5 min of incubation, ∼3. 6 × 10 4 NPs are associated with each cell. Over the next 30 min, rapid accumulation of particles continues, albeit at a slower rate. After 4 h of incubation, there are ∼2.7 × 10 5 SNAs associated with each cell. Note that the cell pellets used to generate the ICP-MS data are red, due to the plasmon resonance of the AuNPs at 520 nm. This red color increases steadily over the first 4 h of incubation (Fig. 2B) . Next, we used confocal microscopy to visualize the transport of Cy5-labeled SNAs (Cy5-SNAs) across the cell membrane and into the cytoplasm (Fig. 2C) . At the initial stages (15 min after introduction of SNAs to cells), the fluorescence signal rises at the cell periphery. Over the next hour, the fluorescence signal moves inward, indicating particle internalization. To characterize the subcellular localization of SNAs, we further used transmission electron microscopy (TEM) to image C166 cells incubated with SNAs (Fig. 2D) . After incubation for 15 min, individual SNA particles are found inside invaginations or small vesicles (∼50 nm in diameter) in the cell membrane, indicating binding and entry of SNAs into cells. Intracellular SNA accumulation becomes more pronounced starting from 30 min after incubation. After 1 h, SNAs are found in larger vesicles (100-250 nm in diameter) that are reminiscent of early endosomes. Indeed, confocal immunofluorescence reveals colocalization between the fluorescent signals of Cy5-SNAs and early endosome antigen-1 (EEA1) at the same time point (Fig. 2E) , confirming sorting of SNAs to early endosomes. Based on both confocal and TEM imaging data, particles never enter the nucleus over the entire incubation period. Thus, the ICP-MS, confocal imaging, and TEM data collectively illustrate three key events that define the endocytosis of SNAs: (i) binding to the cell membrane, (ii) uptake via invaginations, and (iii) sorting into early endosomes. Caveolae/Lipid-Raft as the Major Pathway of Endocytosis. It is important to determine the pathway of endocytosis that is consistent with the rapid uptake kinetics and intracellular transport of SNAs. Since SNAs are localized in vesicles that contain EEA1, such as early endosomes, we focused our attention on clathrin-mediated endocytosis and lipid-raft-mediated endocytosis, both of which can shuttle endocytosed biological molecules to early endosomes (6) . We first examined whether SNA endocytosis is clathrin-mediated. By confocal immunofluorescence, SNAs weakly colocalize with clathrin heavy chain, the basic subunit of the clathrin coat (Fig.  S2A ). Based on ICP-MS measurements made in parallel with the microscopy studies but using different cell samples, pretreatment of C166 cells with chlorpromazine, a pharmacological inhibitor that disrupts the formation of clathrin-coated pits (7), merely reduced the uptake of SNAs by 12% (Fig. S2A) . To probe the role of clathrin with higher specificity, we prepared stably transfected clathrin-deficient C166 cells (denoted "CLTC-DF") by using lentiviruses to deliver GIPZ lentiviral vectors (pGIPZ) that contain a short hairpin RNA (shRNA) sequence for silencing the expression of the CLTC gene, which encodes for clathrin heavy chain (Fig. S4 ). Compared with control C166 cells that were lentivirally transfected with pGIPZ plasmids that do not contain any shRNA (denoted "pGIPZ-control"), CLTC-DF cells exhibited less than 10% reduction in endocytosis of SNAs (Fig. 3E ). These data led us to exclude clathrin-mediated endocytosis as a major pathway for C166 cells.
Finally, we examined whether SNA endocytosis could be mediated by lipid-rafts. Based on confocal immunofluorescence data, Cy5-SNAs exhibit some colocalization with cholera toxin subunit B (CTX-B), caveolin-1 (CAV-1), and flotillin-1 (FLOT-1) (Fig.  3A) , all resident proteins of lipid-rafts (8) . Pretreatment of C166 cells with pharmacological inhibitors that act according to various blocking mechanisms of cholesterol, including methyl-β-cyclodextrin (which depletes and removes cholesterol) and filipin (which sequesters cholesterol) (9), decreased intracellular accumulation of Cy5-SNAs (Fig. S2B) . Remarkably, for filipin-treated cells, Cy5-SNAs are only localized along the cell membrane (as evidenced by the rings of fluorescence) and rarely enter the cytosol (Fig. 3B ). Based on ICP-MS data from independent cell samples, pretreatment with methyl-β-cyclodextrin and filipin reduced the cellular association of SNAs by 49% and 70%, respectively (Fig .  S2B ). We also used TEM to monitor the interaction between SNAs and the cell membrane at the initial stage of endocytosis. After 5 min of incubation, the portion of the cell membrane that contains large amounts of SNAs reveals a darker intensity than portions without SNAs (Fig. 3C) , possibly indicating the presence of lipid-raft microdomains that contain high concentrations of lipidated proteins or transmembrane proteins (10) . These data suggest that the pathway of endocytosis of SNAs is mediated by lipid-rafts and motivated us to further investigate the specific component of lipid-raft involved in the process. The apparent sensitivity of uptake to pretreatment of C166 cells by filipin implies the involvement of caveolae (11) , characterized by flask-shaped 60-80 nm diameter pits that are abundantly found in the membrane of specific cell types, including endothelial cells (12) . Two common classes of endogenous cargo implicated for caveolae- mediated endocytosis are CTX-B (which colocalizes with SNAs in lipid-rafts) and glycosylphosphatidylinositol (GPI)-anchored proteins (13) . Indeed, pretreatment of cells with phosphatidylinositolphospholipase C, which enzymatically cleaves GPI-anchored proteins from the cell membrane (14) , reduced the uptake of SNAs by ∼50% (Fig. S2B) . By TEM imaging, after 5 min of incubation with C166 cells, individual SNAs are localized in flaskshaped invaginations of 50-100 nm in diameter at the cell membrane (Fig. 3D) . To provide direct evidence of caveolae-mediated endocytosis, we generated stable t cells with deficient expression levels of caveolin-1 (denoted "CAV1-DF") by lentiviral transfection of C166 cells with pGIPZ plasmids that contain shRNA sequences for silencing the expression of the CAV1 gene (Figs. S3  and S4 ). Compared with pGIPZ-control cells, CAV1-DF cells exhibited ∼60% reduction in endocytosis of SNAs (Fig. 3E) . Thus, we conclude that lipid-rafts, or more specifically caveolae, significantly mediate the endocytosis of SNAs for C166 cells.
Endocytosis via Class A Scavenger Receptors. Literature precedent has indicated positive correlation between the degree of endocytosis of SNAs and loading density of oligonucleotides (15) . Here, pretreatment of C166 cells with NaN 3 reduced uptake of SNAs by ∼55%, suggesting an energy-dependent nature of endocytosis (Fig.  S5 ). Both observations led us to speculate the presence of cell surface receptors that support multivalent binding with the densely packed oligonucleotides of SNAs. We used ICP-MS to quantify the cellular association of SNAs after incubation for 15 min, a duration of time long enough to allow for binding but not significant cellular uptake (Fig. 2D) . Results from this assay resemble a typical Langmuir binding isotherm for ligand-receptor interactions (Fig. 4A) . Next, we performed a competitive binding assay, in which C166 cells were incubated with a constant amount of SNA-AuNP conjugates (10 nM) and varying amounts of ssDNAs or hollow SNAs for 15 min. This assay allows one to probe the relative importance of multivalent binding involving SNAs; if hollow SNAs compete for surface receptors more effectively than ssDNAs, one can conclude that the polyvalent architecture of SNAs is critical for receptor binding. ICP-MS analysis of the gold content associated with the cells shows that the hollow SNAs are substantially more effective as inhibitors of SNA-AuNP conjugate binding to the cell surface under conditions where the total amount of oligonucleotide is held constant (Fig. 4B) . Therefore, the 3D arrangement of the oligonucleotides contributes to its high binding affinity for cell surface receptors. We previously reported a role for scavenger receptors (SRs) in mediating the endocytosis of SNAs using fucoidan (FCD) and polyinosinic acid (Poly I) as pharmacological inhibitors (16) . Here, we verified that the pretreatment of C166 cells with FCD and Poly I resulted in 80-90% reduction in the uptake of SNAs (Fig. S5) . As FCD and Poly I can bind to more than one member of the SR family (17, 18), they do not allow for the determination of the specific SR member(s) responsible for the endocytosis of SNAs. Based on this result, we can only speculate that class B SRs are not responsible, because FCD and Poly I are not ligands for this receptor subclass (18) . To test this claim, we prepared stable C166 cells that have a deficient expression level of class B scavenger receptor type I, a representative member of the receptor subclass (denoted "SCARB1-DF") by lentiviral transfection of shRNAs targeting the SCARB1 gene. Compared with nontargeting pGIPZ-control cells, SCARB1-DF cells revealed only 25% reduction in uptake of SNAs (Fig. 4C) . To explore the involvement of other SRs, we devised a modified ELISA to measure the binding affinity of SNAs to SRs (Fig. S6A) . Class A SR (SR-A) demonstrates high affinity toward SNAs, netting an apparent binding dissociation constant of ∼5 nM (Fig. 4D) . By contrast, SR-BI does not exhibit appreciable binding to SNAs, in agreement with the uptake data from the use of pharmacological inhibitors (i.e., FCD and Poly I) and SCARB1-DF cells. These data led us to hypothesize the importance of SR-A in mediating the endocytosis of SNAs. We prepared C166 cells deficient in SR-A by lentiviral transfection of shRNAs targeting the macrophage scavenger receptor 1 (MSR1) gene (denoted "MSR1-DF") (Figs. S3 and S4 ). Upon incubation with SNAs, pellets collected from MSR1-DF cells are markedly less red than those from pGIPZ-control cells. Ensuing ICP-MS analysis of the same pellets revealed ∼80% decrease in uptake of SNAs by MSR1-DF cells in contrast to nontargeting pGIPZ-control cells (Fig. 4C ). Since such a degree of decrease matches with that achievable via the use of FCD and Poly I, we conclude that SR-A is an important receptor subclass that mediates the endocytosis of SNAs. To confirm the ability of SR-A to recognize oligonucleotides anchored on SNAs as specific ligands, we incubated SNAs as well as AuNPs that are covalently attached with poly(ethylene glycol) chains (PEG-AuNPs) to different ELISA wells immobilized with recombinant SR-A in parallel. SNAs clearly demonstrate dosedependent binding to SR-As, whereas PEG-AuNPs do not (Fig.  S6B) . We also compared the ability of SNAs and ssDNAs of the same sequence to engage SR-A immobilized on the ELISA plate. Under conditions where the total amount of oligonucleotide is held constant, SNAs can bind to SR-A at least 10 times more strongly than ssDNAs (Fig. S6C ), in agreement with the results from the competitive binding assay conducted using C166 cells (Fig. 4B) . These data confirm that the 3D oligonucleotide shell, not the NP core, dictates the binding of SNAs to SR-A.
Collective Involvement of SR-A and Lipid-Raft Proteins. We further investigated the relationship between the pathway of endocytosis and the cell surface receptor subclass that collectively mediate the endocytosis of SNAs. To this end, we incubated C166 cells with biotin-labeled SNAs (biotin-SNAs) for 2 h, and lysed them with a nondetergent-based method to preserve the native interactions between biotin-SNAs and any cellular proteins that became associated with the biotin-SNAs. To elute the associated proteins, we incubated streptavidin-coated microbeads with the cell lysate overnight, followed by gentle centrifugation of the microbead-lysate mixture to separate the pellet (which contains microbeads presumably attached to biotin-SNAs and their associated proteins) from the supernatant (Fig. 5A) . Western blot analysis of the pellet and supernatant reveals enrichment of lipid-raft proteins (CAV-1 and FLOT-1) and SR-A in the pellet, but not the supernatant. To account for nonspecific binding of proteins onto the microbeads, we performed the identical precipitation assay using lysate from cells transfected with biotinfree SNAs (Fig. 5B) . Western blot analysis of both lysate samples shows no obvious enrichment of lipid-raft proteins or SR-A in the pellet. These results suggest the collective involvement of lipid-rafts and SR-A in mediating the endocytosis of SNAs. In general, NPs or macromolecules can undergo various routes of endocytosis, depending upon their physicochemical parameters (e.g., size, surface charge, and composition), properties of their suspension medium (e.g., dosage concentration, serum proteins), as well as specific cell types tested (19, 20) . In a similar vein as SNAs, several classes of extracellular entities [e.g., proteins (21), bacteria (22) , and NPs (23)] can also enter cells via the lipid-raft/ caveolae pathway through the mediation of SRs.
Effect of CAV-1 and SR-A on Endocytosis of SNAs in Multiple Cell
Types. The above studies strictly involve the use of C166 cells to illustrate the importance of CAV-1 and SR-A in mediating the endocytosis of SNAs. To establish the relevance of the same proteins for cell types other than C166, we measured the uptake kinetics of SNAs for other cell lines and compared the data to their expression of CAV-1 and SR-A. Besides C166, we selected A549 (human lung adenocarcinoma epithelium), 3T3 (mouse fibroblast), and HaCaT (human keratinocyte). These four cell lines possess a vast range of expression levels of CAV-1 and SR-A, and indeed, pretreatment of these cells with FCD and Poly I led to pronounced reduction in their uptake of SNAs (Fig. 6A) . (Fig. 6C) . These data indicate positive correlation between expression level of CAV-1 as well as SR-A and degree of endocytosis of SNAs, and underscore the importance of the same proteins in the endocytosis of SNAs in other cell types.
Conclusions
We have postulated a mechanism that explains the different cellular uptake properties between SNAs and their linear counterparts. For C166 cells, irrespective of the presence of the NP core, SNAs exhibit rapid cellular uptake kinetics and intracellular transport, whereas linear oligonucleotides do not. Moreover, SNAs can compete for cell surface receptors more substantially than linear oligonucleotides, due to the 3D arrangement of oligonucleotides. Specifically, SNAs can bind strongly to the SR-A, which, in turn, significantly mediate the cellular uptake of SNAs. Upon binding to cell surface SR-A, SNAs can enter cells via the caveolae-mediated pathway, presumably due to the close proximity of SNAs, SR-A, and lipid-raft microdomains. Since the expression level of SR-A and CAV-1 correlates positively with the degree of SNA uptake in cell types besides C166 (e.g., fibroblasts, epithelial cells, keratinocytes), we speculate that other cell types also operate under a similar mechanism of endocytosis as proposed for C166 (endothelial) cells. Results herein forge the foundation and reaffirm the potential for using SNA nanostructures as a universal platform for intracellular and in vivo applications, such as diagnostics and gene regulation, in different cell and tissue types.
Materials and Methods
Synthesis of Oligonucleotides. DNAs were synthesized on an MM48 Oligonucleotide synthesizer (BioAutomation) using standard solid-phase synthesis and reagents (Glen Research). All DNAs were purified using a ProStar high performance liquid chromatography (HPLC) instrument (Varian) with a Microsorb C18 column (Varian). Table S1 contains detailed sequence information of the DNAs.
Preparation of SNA Nanoconjugates. Thiolated DNAs were added to 10 nm citrate-capped AuNPs at a concentration of 1 OD of DNA per mL of 10 nM AuNPs supplemented with 0.1% Tween 20. After stirring at RT for 1 h, the solution was aged with gradual additions of NaCl over 6 h to bring the final NaCl concentration to 0.5 M. Functionalized AuNPs were separated from free DNA strands via dialysis against Nanopure water using a 50-kDa Amicon molecular weight cutoff (MWCO) membrane (Millipore). AuNP and DNA concentrations were determined by measuring their extinction at 524 nm and 260 nm, respectively, on a Cary 5000 ultraviolet/visible (UV-Vis) spectrophotometer (Agilent). Hollow SNAs were prepared based on published methods (3).
Generation of Stably Transfected Deficient Cells. Inoculated competent Escherichia coli strains with shRNA-expressing pGITZ vectors were purchased from the Lentiviral shRNA Libraries (Thermo Scientific) through the Northwestern Throughput/RNAi Core. The strains were incubated at 30°C in ampicillin-containing LB broth for 24 h before extraction of plasmids using a QIAGEN Plasmid Plus Maxi Kit (catalog no. 12963). Lentiviral transduction was conducted in the DNA/RNA Delivery Core at Northwestern University. The transduced cells were selected and enriched in DMEM supplemented with 10% (vol/vol) FBS, 2 mM L-glutamine, 100 U/mL penicillin, 100 μg/mL streptomycin, and 8 μg/mL puromycin.
Uptake Kinetics and Binding Assays. Seeded in a 24-well plate at a population of 5 × 10 4 cells per well 12 h in advance, cells were incubated with 0.3 mL of SNAs (10 nM in OptiMEM; Invitrogen) per well at 37°C and 5% CO 2 . To measure uptake kinetics, SNAs were removed at different time points, followed by OptiMEM rinses, trypsinization for counting using a hemacytometer, and centrifugation at 8,000 rpm for 5 min to form a pellet for quantification by ICP-MS and imaging by TEM. For the direct binding assay, cells were incubated with different concentrations of SNAs for 15 min. For the competitive binding assay, cells were incubated with a mixture that contains 10 nM of SNAs and different concentrations of hollow SNAs for 15 min. Cells were later pelleted for ICP-MS analysis.
ICP-MS.
Cell pellets were digested with 0.3 mL of 3% HCl in concentrated HNO 3 at RT overnight. After adding 5 μL of 5 ppm indium (internal standard) and 5 mL of matrix solution (2% HCl and 2% HNO 3 ), the Au-197 content of the resultant solution was measured by an X Series II ICP-MS (ThermoFisher) after subtracting the background gold content of untreated cells. Unless otherwise mentioned, reported values represent mean ± SE from the average of three independent experiments.
TEM. Cell pellets were resuspended in 0.2 mL of molten 4% gelatin in PBS and pelleted again by centrifugation at 15,000 rpm for 5 min. Embedded in congealed gelatin, cells were fixed in 2.5% glutaraldehyde in 100 mM sodium cacodylate buffer (pH = 7.4), stained by 1% OsO 4 , and by 0.9% 
